These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
33. Protective efficacy of antibodies to the Staphylococcus aureus type 5 capsular polysaccharide in a modified model of endocarditis in rats. Lee JC; Park JS; Shepherd SE; Carey V; Fattom A Infect Immun; 1997 Oct; 65(10):4146-51. PubMed ID: 9317020 [TBL] [Abstract][Full Text] [Related]
34. Aspirin plus ticlopidine prevented experimental endocarditis due to Enterococcus faecalis and Streptococcus gallolyticus. Veloso TR; Oechslin F; Que YA; Moreillon P; Entenza JM; Mancini S Pathog Dis; 2015 Nov; 73(8):ftv060. PubMed ID: 26310867 [TBL] [Abstract][Full Text] [Related]
35. In vivo activity of evernimicin (SCH 27899) against methicillin-resistant Staphylococcus aureus in experimental infective endocarditis. Boucher HW; Thauvin-Eliopoulos C; Loebenberg D; Eliopoulos GM Antimicrob Agents Chemother; 2001 Jan; 45(1):208-11. PubMed ID: 11120967 [TBL] [Abstract][Full Text] [Related]
37. Comparison of ampicillin-sulbactam with vancomycin for treatment of experimental endocarditis due to a beta-lactamase-producing, highly gentamicin-resistant isolate of Enterococcus faecalis. Lavoie SR; Wong ES; Coudron PE; Williams DS; Markowitz SM Antimicrob Agents Chemother; 1993 Jul; 37(7):1447-51. PubMed ID: 8363374 [TBL] [Abstract][Full Text] [Related]
38. Maltohexaose-indocyanine green (MH-ICG) for near infrared imaging of endocarditis. Takemiya K; Røise JJ; He M; Taing C; Rodriguez AG; Murthy N; Goodman MM; Taylor WR PLoS One; 2021; 16(3):e0247673. PubMed ID: 33647027 [TBL] [Abstract][Full Text] [Related]
39. Lack of extracellular slime effect on treatment outcome of Staphylococcus epidermidis experimental endocarditis. Steckelberg JM; Keating MR; Rouse MS; Wilson WR J Antimicrob Chemother; 1989 Jan; 23(1):117-21. PubMed ID: 2745247 [TBL] [Abstract][Full Text] [Related]